Highly regioselective 4-hydroxy-1-methylpiperidine mediated aromatic nucleophilic substitution on a perfluorinated phthalimide core by Madácsi, Ramóna et al.
Accepted Manuscript
Title: Highly regioselective 4-hydroxy-1-methylpiperidine
mediated aromatic nucleophilic substitution on a
perfluorinated phthalimide core
Authors: Ramo´na Mada´csi, Ma´rio´ Gyuris, Ja´nos Wo¨lfling,
La´szlo´ G. Puska´s, Iva´n Kanizsai
PII: S0022-1139(18)30139-8
DOI: https://doi.org/10.1016/j.jfluchem.2018.05.011
Reference: FLUOR 9174
To appear in: FLUOR
Received date: 29-3-2018
Revised date: 23-5-2018
Accepted date: 26-5-2018
Please cite this article as: Mada´csi R, Gyuris M, Wo¨lfling J, Puska´s LG, Kanizsai
I, Highly regioselective 4-hydroxy-1-methylpiperidine mediated aromatic nucleophilic
substitution on a perfluorinated phthalimide core, Journal of FluorineChemistry (2018),
https://doi.org/10.1016/j.jfluchem.2018.05.011
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
 
1 
Highly regioselective 4-hydroxy-1-methylpiperidine mediated aromatic 
nucleophilic substitution on a perfluorinated phthalimide core 
Ramóna Madácsia,b, Márió Gyurisa, János Wölflingb, László G. Puskása, Iván Kanizsaia,* 
 
aAVIDIN Ltd. – Alsó Kikötő sor 11/D, H-6726, Szeged, Hungary 
bDepartment of Organic Chemistry, Faculty of Science and Informatics, University of Szeged, Dóm tér 8, 
H-6720, Szeged, Hungary 
 
 
 
Graphical asbtract 
 
 
 
 
 
Highlights 
 
 1-methyl-4-hydroxypiperidine mediated highly regioselective SNAr protocol was 
developed. 
 The inherent regioselectivities were modified towards the less favoured bioactive 
regioisomer. 
 The optimal condition could be utilized for gram scale synthesis.  
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Abstract 
 
A tertiary amine-mediated highly regioselective aromatic nucleophilic substitution (SNAr) 
protocol was developed in the assemblies of perfluorinated phtalimide with primary or secondary 
amines as inputs. Application of 1-methyl-4-hydroxypiperidine as additive, formation of the less 
favoured, bioactive regioisomer was facilitated, modifying their ratios from the initial 8-36% to 
81-91%. After optimization, a facile gram scale syntheses were accomplished and isolated the 
desired analogues in up to 63% yield.  
Keywords: aromatic nucleophilic substitution, SNAr, phtalimide, regioselective, tertiary amine 
1. Introduction 
 
The selective decoration of (hetero)aromatic scaffolds is an undoubtedly essential synthetic tool 
in medicinal chemistry in order to generate a diverse set of compounds having the best balance of 
pharmacological properties. The most commonly used techniques for this purpose include either 
the transition metal-catalyzed, or the aromatic nucleophilic substitution (SNAr) reactions [1,2]. 
The outcome of SNAr transformations strongly depends on the simultaneous interplay between 
several parameters, such as, for instance, the overall electronics of the (hetero)arene affected by 
the substitution pattern, the influence and mobility of the leaving group, the nature of the 
nucleophile applied, solvent and medium effects, stability of the intermediate σ-complex, etc [3]. 
It should be emphasized, that hydrogen bonding between an SNAr donor and acceptor may 
account for specific solvent effect on the regioselectivity [3,4]. For instance, ortho selectivity was 
observed in the reaction of 2,4-difluoroacetophenone with secondary amines in non-polar solvents 
(toluene, dioxane, etc.) [5]. In this case, precoordination of the amine to the carbonyl function via 
H-bond formation may occur, and intramolecular hydrogen bond stabilization (inverted built - in 
solvation) may operate in the transition state, preferring the ortho-displacement supported by the 
solvent. In contrast, solvents having high solvent hydrogen bond basicity (SHBB) (e.g. DMSO) 
result in para-displacement. The reversed selectivity can be interpreted by the lack of a transition 
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state stabilized by H-bond and a relatively strong H-bond interaction between the polar solvent 
and the nucleophile applied. 
There are certain SNAr synthetic ‘tricks’ described in the literature, which, in contrast to the 
general considerations, led to either improved conversion or regioselectivity [6-8]. For instance, a 
regioselective DABCO-catalyzed two-stage sequential SNAr reaction of methyl 2,6-
dichloronicotinate with phenols was first introduced by Merck Research Laboratories [6]. Besides 
the remarkable solvent effect observed, the reaction proceeds through the regioselective generation 
of an unprecedented DABCO–pyridine reactive intermediate. As disclosed by Amgen Inc., certain 
ortho-heteroaryl substituents, relative to the leaving group, exert moderate electron-withdrawing 
effects. As a result, they are able to facilitate the SNAr reactions via preferential hydrogen bond 
formation between the directing group and the amine nucleophile, thereby stabilizing the transition 
state [7]. Furthermore, O’Reilly and co-workers have demonstrated the potential of metal ions 
such as Rh3+ to increase the electrophilicity of electron-rich fluoroarenes and allow the initia t ion 
SNAr for even weak nucleophiles [8]. The nucleophile and ‘host’ fluoroarene are coordinated to 
the metal prior to nucleophilic attack. 
In a recent medicinal chemistry program, we have synthesized and evaluated a large set of 4- and 
5-amino-substituted perfluorophthalimide derivatives via SNAr reactions [9-11]. In most cases, 
regioisomer a exerted excellent cytotoxicity in different cell lines including melanoma, leukemia, 
hepatocellular carcinoma, glioblastoma at micromolar concentrations. Unfortunately, the reaction 
mixtures contained predominantly the less or non-active isomer b. This required a relative ly 
expensive, difficult and long isolation process resulting in low isolated yields. Therefore, our goal 
was to develop a regioselective and cost-efficient SNAr reaction between the privileged C4-C7 
perfluorinated phatlimide core and various amines towards the active C-4 (ortho) substituted 
isomers (Figure 1). 
 
2. Results and discussion 
Selected primary and secondary amines were reacted with 1 under general conditions we applied 
earlier. That is, two equivalents of the corresponding amine in DCM at room temperature were 
reacted to obtain preliminary data in terms of yields and isomer ratios (Scheme 1 and Table 1). 
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As expected, the desired analogues 2a–8a were detected as minor components (up to 39% 
conversion by HPLC), and poor HPLC yields (6–34%) were obtained. 
 
 Compounds were characterized by means of 1H- 19F- 13C-NMR and mass-spectrometry. In 
addition, the exact structures of regioisomers 4a and 4b were defined by XRD analysis (See 
detailed X-Ray crystallographic data and molecular structure in the Supporting Information). 
 In order to investigate the effect of additives on the regioselectivity, first the possible role of 
Lewis acid activators was tested. For this purpose, several salts were examined in a model SNAr 
reaction between 1 and morpholine in DCM (see Supplementary Information, Table S1, Entries 
1–39). Unfortunately, most of the additives did not lead to either improved isomer ratios or yields 
in favour of isomer 2b. However, using iron(III)-based Lewis acids, such as FeCl3·6H2O or 
Fe(NO3)3·6H2O, moderately altered ratios (2a:2b= 30:70 to 53:47) were observed. Therefore, 
FeCl3·6H2O was selected for further investigations in the Lewis acid-mediated SNAr optimiza t ion 
phase. 
As a continuation of our study, the optimal equivalent of amine and FeCl3·6H2O were identified 
(see Supplementary Information, Table S2 and S3, Entries 40–48). Employing one equivalent of 
morpholine along with 50 mol% of FeCl3·6H2O in DCM gave improved selectivity for isomer 2a 
(2a:2b= 68:32%). Next, we investigated the solvent effects in the model reaction in terms of 
selectivity and conversion (see Supplementary Information, Table S4). Some polar-aprotic 
solvents (DMSO, CH3CN and THF) and non-polar–aprotic toluene were tested besides DCM. To 
our delight, toluene as solvent was proved to be an excellent reaction medium to gain good ortho 
selectivity (2a:2b = 84:16%) and high conversion in favour of isomer 2a.  
Then we attempted to extend these conditions by means of different amine sources (Scheme2 
and Table 2). For N-methylethanolamine, a rather meager regioselectivity was detected (6a:6b= 
48:52%). Moreover, no conversions were observed using 4-piperidinol (3) and thiomorpholine (7). 
Presumably, the formation of 3a,3b or 7a,7b is hindered due to a unsoluble metal salt–amine 
complex formed in the reaction, since the addition of few drops of water into the reaction mixture 
induced the reactions (data not shown). Hence, further experiments were focused on reactions 
performed in toluene–water reaction medium. 
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The synthesis of 3, 6, 7 and 8 were repeated in a toluene-water (1:1) solvent mixture without 
using any additives in the first instance (Scheme 3 and Table 3). Interestingly, the toluene–water 
system increased the conversion in cases of 3, 6 and 7. Surprisingly and more importantly, the 
reaction of 4-piperidinol and 1 led to the exclusive formation of isomer 3a. Presumably, a hydrogen 
bond is formed between the host (–C=O) and the guest (–OH), resulting in a sort of kinetic control 
favouring the ortho SNAr selectivity. This observation gave a completely new direction for the 
synthetic development of regioselective SNAr reactions in our model system. We hypothesized, 
that if the tertiary 1,3-aminoalcohol, which is converted to a quaternary ammonium cation after 
the first displacement, can serve as the leaving group, we might have control over the selectivity 
through a two-stage sequential SNAr. Therefore, we turned our attention to select suitable tertiary 
amines as potential leaving groups. Besides, further studies for revealing the synthetic and 
theoretical aspects and background of a regioselective Fe(III)-mediated SNAr reactions are 
ongoing in our laboratory. 
As regards the tertiary amine-promoted selective SNAr strategy, we assumed that 1-methyl-4-
piperidinol as an 1,3-aminoalcohol promoter might be a suitable additive for influencing the 
favourable regioselectivity based on our observation described earlier. Other 1,2- and 1,3-
aminoalcohols with tertiary amine moieties were also tested besides DABCO and DBU for having 
a full scope. In addition, the less selective SNAr reaction, namely, the reaction of N-
ethylaminoethanol and phthalimide derivative 1 was selected for these studies (Scheme 4 and 
Table 4).  
The reaction of 1 with 1-methyl-4-hydroxypiperidine followed by subsequent treatment with N-
ethylethanolamine gave regioisomer 8a with 88% conversion (total conversion: 95% by HPLC). 
Based on these findings, additional amines have been applied without any further optimization in 
the presence of 1-methyl-4-hydroxy piperidine, and in all cases the desired 2a–8a isomers were 
detected as major components with excellent regioselectivity up to 91% (Scheme 5 and Table 5). 
Finally, the well-established regioselective SNAr protocol was repeated on a gram scale, 
affording the desired isomers 2a–8a with isolated yields up to 63% (Figure 2).  
3. Conclusion 
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In this study we presented a novel, tertiary amine-mediated highly regioselective SNAr method. 
The formation of the less favoured regioisomer was facilitated in the presence of equimolar tert-
1,3-aminoalcohol. This facile protocol gave a simple and selective access to pharmacologica l ly 
relevant compounds even on a gram scale. 
4. Experimental section 
1H-NMR spectra were recorded on a Bruker Spectrospin 500 spectrometer. Chemical shifts (in 
ppm) were referenced to tetramethylsilane (δ = 0 ppm) in CDCl3-d1 as an internal standard. 13C-
NMR spectra were obtained by using the same NMR spectrometer and were calibrated with 
CDCl3-d1 (δ = 76.6 ppm). 19F-NMR spectra were obtained by using the same NMR spectrometer.  
Mass spectra were recorded by Micromass ZMD spectrometer. IR spectra were recorded by Jasco 
FT/IR-4700 spectrometer (ATR PRO ONE; ZnSe). Elemental analyses were performed using a 
Perkin Elmer 2400 elementary analyzer. Melting points were determined by a Stuart SMP10 
device, and they are uncorrected. All chemicals and solvents were of commercial grade and used 
without further purification. For X-ray diffraction measurement see Supplementary Information 
CCDC 1843621-1843622. 
 
4.1. General procedure for the syntheses of compounds 2–8 for HPLC: 
To a solution of 50 mg (0.13 mmol) 1 in toluene–water (1:1) (0.5 mL) was added 15 mg (0.13 
mmol, 1 equiv) 1-methyl-4-hydroxypiperidine, and the reaction mixture was stirred at room 
temperature for 36 hours. Then one equivalent of the corresponding amine was added, and the 
reaction mixture was stirred for an additional 24 hours at room temperature. The reaction was 
monitored by TLC (eluent: n-hexane:EtOAc). The mixture after complete reaction was evaporated 
to dryness and prepared for the HPLC measurements for detecting regioisomeric ratios. 
4.2. Gram-scale synthetic procedure for compounds 2a-8a: 
To a solution of 3.0g (7.8 mmol) 1 in toluene–water mixture (1:1) (30 mL) was added 911 mg 
(7.8 mmol, 1 equiv) 1-methyl-4-hydroxypiperidine, and the reaction mixture was stirred at room 
temperature for 36 hours. Then one equivalent amine was added slowly, and the reaction mixture 
was stirred for an additional 24 hours at room temperature. The reaction was monitored by TLC 
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(eluent: n-hexane:EtOAc 6:1). Once the reaction was completed, the mixture was diluted with 
ethyl acetate (100 mL), and the organic phase was extracted with water (2 x 100 mL). The organic 
phase was dried over Na2SO4, filtered and evaporated. The crude products were purified by flash 
chromatography (CombiFlash, Rf Gold column). 
4.2.1. 2-(2,6-Diisopropylphenyl)-4,5,6-trifluoro-7-morpholinoisoindoline-1,3-dione (2a) 
Yellow solid. m.p.: 146–148°C. TLC: Rf=0.31 (hexane:EtOAc=6:1). C24H25F3N2O3. Elemental 
analysis: Calcd.: C 64.56, H 5.64, N 6.27. Found: C 67.56, H 5.64, N 6.28. IR (ATR PRO ONE; 
ZnSe) ν = 1401, 1499, 1503, 1630, 1723, 1778, 2878, 2932, 2972 cm-1; 1H NMR (500 MHz, CDCl3 
with 0.03 % TMS) δ 1.17 (t, J = 6.9 Hz, 4 CH3), 2.67 (h, J = 7.3 Hz, 2 CH), 3.39–3.48 (m, 2 CH2), 
3.80–3.88 (m, 2 CH2), 7.28 (d, J = 7.4 Hz, 2 ArH), 7.44 (t, J = 7.8 Hz, ArH). 13C-NMR (126 MHz, 
CDCl3) δ (ppm): 23.5, 23.6, 29.0, 51.7, 51.8, 66.9, 114.2–114.4 (m), 114.6–114.9 (m), 123.7, 
126.0, 130.0, 135.9 (d, J = 8.0 Hz), 140.2 (d, J = 11.6 Hz), 142.3 (d, J = 11.0 Hz), 143.3–143.7 
(m), 145.4–145.8 (m), 146.2, 148.5 (dd, J = 261.1 Hz, 10.7 Hz), 162.8, 164.3. 19F NMR (471 MHz, 
DMSO) δ (ppm): -133.00 (d, J = 14.1 Hz), -143.81 (dd, J = 22.6, 6.1 Hz), -147.75 (dd, J = 22.1, 
16.8 Hz). MS (ESI) m/z =447 [(M+H)+]. 
4.2.2. 2-(2,6-Diisopropylphenyl)-4,5,7-trifluoro-6-morpholinoisoindoline-1,3-dione (2b) 
Yellow solid. m.p.: 105–107°C. TLC: Rf=0.22 (hexane:EtOAc=6:1). C24H25F3N2O3. Elementa l 
analysis: Calcd.: C 64.56, H 5.64, N 6.27. Found: C 67.57, H 5.66, N 6.26. IR (ATR PRO ONE; 
ZnSe) ν = 1361, 1407, 1486, 1498, 1628, 1716, 1770, 2845, 2867, 2920, 2963 cm-1; 1H NMR (500 
MHz, CDCl3 with 0.03 % TMS) δ 1.17 (t, J = 6.5 Hz, 4 CH3), 2.68 (h, J = 7.2 Hz, 2 CH), 3.42–
3.48 (m, 2 CH2), 3.81–3.88 (m, 2 CH2), 7.28 (d, J = 7.8 Hz, 2 ArH), 7.46 (t, J = 7.6 Hz, ArH). 13C-
NMR (126 MHz, CDCl3) δ (ppm): 23.6, 29.0, 29.3, 50.6, 66.7, 112.9–113.3 (m), 123.6, 125.7, 
130.0, 135.4–135.6 (m), 144.6–145.0 (m), 146.8, 162.7, 163.7. 19F NMR (471 MHz, DMSO) δ 
(ppm): -124.12 (t, J = 14.9 Hz), -135.15–-135.88 (m), -139.79 (dd, J = 20.5, 16.1 Hz). MS (ESI) 
m/z =447 [(M+H)+]. 
4.2.3. 2-(2,6-Diisopropylphenyl)-4,5,6-trifluoro-7-(4-hydroxypiperidin-1-yl)isoindoline-1,3-
dione (3a) 
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Yelllow solid. m.p.: 153–155°C. TLC: Rf=0.10 (hexane:EtOAc=4:1). C25H27F3N2O3. Elemental 
analysis: Calcd.: C 65.21, H 5.91, N 6.08. Found: C 65.22, H 5.90, N 6.08. IR (ATR PRO ONE; 
ZnSe) ν = 1456, 1504, 1713, 1766, 2870, 2928, 2960, 3268 cm-1; 1H NMR (500 MHz, CDCl3 with 
0.03 % TMS) δ 1.17 (t, J = 7.1 Hz, 4 CH3), 1.70–1.82 (m, CH2), 1.98–2.08 (m, CH2), 2.67 (h, 2 
CH), 3.31 (t, J = 10.9 Hz, CH2), 3.49–3.60 (m, CH2), 3.85–3.94 (m, CH), 7.28 (d, J = 9.7 Hz, 2 
ArH), 7.44 (t, J = 7.8 Hz, ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 23.5, 23.6, 28.9, 34.4, 
49.2, 49.3, 66.7, 114.1, 114.6 (d, J = 8.0 Hz), 123.6, 126.1, 129.9, 136.6 (d, J = 8.0 Hz), 141.1 (dd, 
J = 265.4 Hz, 12.5 Hz), 143.2–145.8 (m), 146.8, 149.7 (dd, J = 259.2 Hz, 10.7 Hz), 162.9, 164.4. 
19F NMR (471 MHz, DMSO) δ (ppm): -132.65 (d, J = 14.5 Hz), -144.55 (dd, J = 22.6, 5.6 Hz), -
148.03 (dd, J = 22.1, 17.1 Hz). MS (ESI) m/z =461 [(M+H)+].  
4.2.4. 2-(2,6-Diisopropylphenyl)-4,5,7-trifluoro-6-(4-hydroxypiperidin-1-yl)isoindoline-1,3-
dione (3b) 
Pale yellow solid. m.p.: 177–179°C. TLC: Rf=0.06 (hexane:EtOAc=4:1). C25H27F3N2O3. 
Elemental analysis: Calcd.: C 65.21, H 5.91, N 6.08. Found: C 65.23, H 5.90, N 6.08. IR (ATR 
PRO ONE; ZnSe) ν = 1483, 1701, 1758, 2853, 2910, 2960, 3236 cm-1; 1H NMR (500 MHz, CDCl3 
with 0.03 % TMS) δ 1.16 (d, J = 6.9 Hz, 4 CH3), 1.66–1.75 (m, CH2), 1.98–2.05 (m, CH2), 2.68 
(h, 2 CH), 3.28 (t, J = 10.6 Hz, CH2), 3.57–3.65 (m, CH2), 3.89–3.98 (m, CH), 7.27 (d, J = 7.9 Hz, 
2 ArH), 7.45 (t, J = 7.8 Hz, ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 23.6, 28.9, 34.3, 48.0, 
66.4, 108.4 (d, J = 10.7 Hz), 112.9 (d, J = 11.8 Hz), 123.6, 125.8, 130.0, 136.3–136.8 (m), 143.8 
(dd, J = 266.4 Hz, 5.9 Hz), 146.6–146.8 (m), 146.9, 147.0–147.4 (m), 148.7–148.9 (m), 149.0–
149.9 (m), 162.9, 163.4. 19F NMR (471 MHz, DMSO) δ (ppm): -124.18 (t, J = 15.2 Hz), -136.05 
(dd, J = 18.6, 17.6 Hz), -139.82 (dd, J = 20.6, 15.9 Hz). MS (ESI) m/z =461 [(M+H)+].  
4.2.5. 2-(2,6-Diisopropylphenyl)-4-(ethylamino)-5,6,7-trifluoroisoindoline-1,3-dione (4a) 
Orange solid. m.p.: 147–149°C. TLC: Rf=0.57 (hexane:EtOAc=6:1). C22H23F3N2O2. Elemental 
analysis: Calcd.: C 65.34, H 5.73, N 6.93. Found: C 65.35, H 5.72, N 6.92. IR (ATR PRO ONE; 
ZnSe) ν = 1460, 1496, 1512, 1702, 1720, 1766, 1779, 2872, 2932, 2971, 3370 cm-1; 1H NMR (500 
MHz, CDCl3 with 0.03 % TMS) δ 1.17 (d, J = 6.8 Hz, 4 CH3), 1.32 (t, J = 7.2 Hz, CH3), 2.69 (h, 
J = 6.8 Hz, 2 CH), 3.55–3.63 (m, CH2), 6.35–6.40 (m, NH), 7.28 (d, J = 7.8 Hz, 2 ArH), 7.45 (t, J 
= 7.8 Hz, ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 15.7, 23.5, 23.6, 28.9, 39.4, 39.5, 104.9 (d, 
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J = 10.0 Hz), 112.7–113.0 (m), 123.6, 125.7, 129.9, 134.9 (d, J = 10.0 Hz), 137.9 (dd, J = 263.0 
Hz, 15.0 Hz), 142.6–142.9 (m), 144.2–145.0 (m), 146.3–146.8 (m), 147.0, 163.1, 168.0. 19F NMR 
(471 MHz, DMSO) δ (ppm): -142.16 (d, J = 15.1 Hz), -148.55 (dd, J = 22.0, 15.7 Hz), -149.74 (t, 
J = 30.6 Hz). MS (ESI) m/z =405 [(M+H)+]. The structure of the molecule was verified using 
single crystal X-ray diffraction measurement.  
4.2.6. 2-(2,6-Diisopropylphenyl)-5-(ethylamino)-4,6,7-trifluoroisoindoline-1,3-dione (4b) 
Pale yellow solid. m.p.: 169–171°C. TLC: Rf=0.33 (hexane:EtOAc=6:1). C22H23F3N2O2. 
Elemental analysis: Calcd.: C 65.34, H 5.73, N 6.93. Found: C 65.34, H 5.71, N 6.92. IR (ATR 
PRO ONE; ZnSe) ν = 1501, 1701, 1753, 2836, 2930, 2972, 3368 cm-1; 1H NMR (500 MHz, CDCl3 
with 0.03 % TMS) δ 1.17 (d, J = 6.8 Hz, 4 CH3), 1.32 (t, J = 7.2 Hz, CH3), 2.71 (m, 2 CH), 3.48–
3.83 (m, CH2), 4.39–4.58 (m, NH), 7.27 (d, J = 7.8 Hz, 2 ArH), 7.45 (t, J = 7.8 Hz, ArH). 13C-
NMR (126 MHz, CDCl3) δ (ppm): 15.8, 23.6, 28.9, 39.9, 103.4 (d, J = 11.0 Hz), 113.0 (d, J = 12.0 
Hz), 123.5, 125.9, 129.9, 133.7–134.1 (m), 141.2–141.8 (m), 143.8 (dd, J = 264.0 Hz, 13.5 Hz), 
143.3–143.8 (m), 146.9, 163.2, 163.5. 19F NMR (471 MHz, DMSO) δ (ppm): -133.29 (dd, J = 
18.7, 15.1 Hz), -141.01 (dd, J = 20.2, 14.0 Hz), -148.82 (t, J = 20.3 Hz). MS (ESI) m/z =405 
[(M+H)+]. The structure of the molecule was verified using single crystal X-ray diffract ion 
measurement. 
4.2.7. 4-(Cyclopentylamino)-2-(2,6-diisopropylphenyl)-5,6,7-trifluoroisoindoline-1,3-dione (5a) 
Yellow solid. m.p.: 118–120°C. TLC: Rf=0.69 (hexane:EtOAc=6:1). C25H27F3N2O2. Elemental 
analysis: Calcd.: C 67.55, H 6.12, N 6.30. Found: C 67.52, H 6.12, N 6.31. IR (ATR PRO ONE; 
ZnSe) ν = 1467, 1483, 1504, 1613, 1650, 1700, 1768, 2870, 2929, 2962, 3350 cm-1; 1H NMR (500 
MHz, CDCl3 with 0.03 % TMS) δ 1.17 (dd, J = 6.8 Hz, 2.2 Hz, 4 CH3), 1.54–1.71 (m, 2 CH2), 
1.72–1.83 (m, CH2), 1.98–2.10 (m, CH2), 2.69 (h, 2 CH), 4.23–4.34 (m, CH), 6.43 (d, J = 7.4 Hz, 
NH), 7.27 (d, J = 7.9 Hz, 2 ArH), 7.45 (t, J = 7.8 Hz, ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 
23.0, 23.5, 23.6, 28.9, 34.2, 55.9, 56.0, 105.1 (d, J = 8.0 Hz), 112.7–113.1 (m), 123.6, 125.7, 129.9, 
134.5 (d, J = 9.0 Hz), 137.9 (dd, J = 263.0 Hz, 15.0 Hz), 142.3–142.8 (m), 144.1–144.8 (m), 146.2–
146.7 (m), 146.9, 163.1, 168.0. 19F NMR (471 MHz, DMSO) δ (ppm): -140.64 (d, J = 15.3 Hz), -
148.18 (dd, J = 22.0, 16.0 Hz), -148.59 (d, J = 22.2 Hz). MS (ESI) m/z =445 [(M+H)+]. 
4.2.8. 5-(Cyclopentylamino)-2-(2,6-diisopropylphenyl)-4,6,7-trifluoroisoindoline-1,3-dione (5b) 
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Pale yellow solid. m.p.: 164–167°C. TLC: Rf=0.45 (hexane:EtOAc=6:1). C25H27F3N2O2.  
Elemental analysis: Calcd.: C 67.55, H 6.12, N 6.30. Found: C 67.54, H 6.11, N 6.29. IR (ATR 
PRO ONE; ZnSe) ν = 1432, 1474, 1630, 1689, 2868, 2912, 2953, 3420 cm-1; 1H NMR (500 MHz, 
CDCl3 with 0.03 % TMS) δ 1.17 (d, J = 6.8 Hz, 4 CH3), 1.51–1.63 (m, CH2), 1.64–1.85 (m, 2 CH2), 
2.04–2.15 (m, CH2), 2.71 (h, 2 CH), 4.30–4.43 (m, NH, CH), 7.27 (d, J = 7.8 Hz, 2 ArH), 7.45 (t, 
J = 7.8 Hz, ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 23.2, 23.6, 28.9, 34.3, 56.2, 113.1 (d, J = 
12.0 Hz), 123.5, 126.0, 133.4–133.7 (m), 141.1–141.4 (m), 143.1–143.5 (m), 144.7–145.0 (m), 
146.9, 163.2, 163.5. 19F NMR (471 MHz, DMSO) δ (ppm): -131.74 (dd, J = 17.2, 16.2 Hz), -140.87 
(dd, J = 20.4, 14.0 Hz), -147.02 (t, J = 20.2 Hz).MS (ESI) m/z =445 [(M+H)+]. 
4.2.9. 2-(2,6-Diisopropylphenyl)-4,5,6-trifluoro-7-((2-hydroxyethyl)(methyl)amino)isoindoline-
1,3-dione (6a) 
Yelllow solid. m.p.: 127-130°C. TLC: Rf=0.18 (hexane:EtOAc=4:1). C23H25F3N2O3. Elementa l 
analysis: Calcd.: C 63.59, H 5.80, N 6.45. Found: C 63.57, H 5.81, N 6.46. IR (ATR PRO ONE; 
ZnSe) ν = 1465, 1490, 1632, 1643, 1698, 1722, 1758, 1782, 2871, 2929, 2972, 3360 cm-1; 1H NMR 
(500 MHz, CDCl3 with 0.03 % TMS) δ 1.15 (d, J = 6.8 Hz, 2 CH3), 1.18 (d, J = 6.8 Hz, 2 CH3), 
2.65 (h, J = 6.7 Hz, 2 CH), 2.71–2.79 (m, OH), 3.06 (d, J = 1.6 Hz, CH3), 3.47 (t, J = 4.8 Hz, CH2), 
3.72–3.79 (m, CH2), 7.29 (d, J = 7.7 Hz, 2 ArH), 7.46 (t, J = 7.9 Hz, ArH), 13C-NMR (126 MHz, 
CDCl3) δ (ppm): 23.5, 29.0, 40.2, 40.9, 56.9, 57.0, 58.6, 123.7, 125.8, 130.1, 142.4 (dd, J = 264.0 
Hz, 15.0 Hz), 144.5 (dd, J = 261.0 Hz, 15.0 Hz), 146.7, 151.4 (dd, J = 264.0 Hz, 11.0 Hz), 162.7, 
165.3. MS (ESI) m/z =435 [(M+H)+].  
4.2.10. 2-(2,6-Diisopropylphenyl)-4,5,7-trifluoro-6-((2-hydroxyethyl)(methyl)amino)isoindoline-
1,3-dione (6b) 
Pale yellow solid. m.p.: 80-83°C. TLC: Rf=0.08 (hexane:EtOAc=4:1). C23H25F3N2O3. Elemental 
analysis: Calcd.: C 63.59, H 5.80, N 6.45. Found: C 63.56, H 5.80, N 6.43. IR (ATR PRO ONE; 
ZnSe) ν = 1450, 1462, 1620, 1713, 1765, 2870, 2925, 2968, 3349 cm-1; 1H NMR (500 MHz, CDCl3 
with 0.03 % TMS) δ 1.17 (d, J = 6.9 Hz, 4 CH3), 2.22–2.51 (m, OH), 2.69 (h, J = 6.8 Hz, 2 CH), 
3.13–3.16 (m, CH3), 3.51 (t, J = 5.3 Hz, CH2), 3.86 (t, J = 5.3 Hz, CH2), 7.28 (d, J = 7.8 Hz, 2 
ArH), 7.46 (t, J = 7.5 Hz, ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 23.6, 28.9, 40.4, 56.6, 
59.7, 109.1 (d, J = 10.9 Hz), 112.9 (d, J = 13.2 Hz), 115.5, 123.1, 123.6, 125.6, 130.0, 136.9 (t, J 
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= 11.3 Hz), 143.7 (dd, J = 267.4 Hz, 14.7 Hz), 146.9, 148.2 (dd, J = 263.8 Hz, 5.0 Hz), 148.8 (ddd, 
J = 255.2 Hz, 13.6 Hz, 5.4 Hz), 162.8, 163.4. 19F NMR (471 MHz, DMSO) δ (ppm): -123.30 (t, J 
= 15.0 Hz), -135.91 (t, J = 17.8 Hz), -140.18 (dd, J = 20.0, 15.6 Hz). MS (ESI) m/z =435 [(M+H)+]. 
4.2.11. 2-(2,6-Diisopropylphenyl)-4,5,6-trifluoro-7-thiomorpholinoisoindoline-1,3-dione (7a) 
Yellow solid. m.p.: 181–183°C. TLC: Rf=0.55 (hexane:EtOAc=6:1). C24H25F3N2O2S. Elemental 
analysis: Calcd.: C 62.32, H 5.45, N 6.06. Found: C 62.34, H 5.44, N 6.08. IR (ATR PRO ONE; 
ZnSe) ν = 1478, 1495, 1630, 1722, 1781, 2880, 2940, 2973 cm-1; 1H NMR (500 MHz, CDCl3 with 
0.03 % TMS) δ 1.17 (t, J = 6.2 Hz, 4 CH3), 2.66 (h, J = 6.7 Hz, 2 CH), 2.78–2.84 (m, 2 CH2), 
3.60–3.66 (m, 2 CH2), 7.28 (d, J = 7.9 Hz, 2 ArH), 7.46 (t, J = 7.6 Hz, ArH). 13C-NMR (126 MHz, 
CDCl3) δ (ppm): 23.5, 23.6, 27.6, 29.0, 53.9, 54.0, 114.7 (d, J = 6.2 Hz), 115.1, 123.7, 126.0, 
126.8, 129.7, 130.0, 136.7 (d, J = 6.7 Hz), 141.6 (dd, J = 265.7 Hz, 12.9 Hz), 144.5 (dt, J = 262.7 
Hz, 15.6 Hz), 146.7, 150.0 (dd, J = 259.2 Hz, 10.8 Hz), 162.7, 164.2. 19F NMR (471 MHz, DMSO) 
δ (ppm): -131.50 (d, J = 12.4 Hz), -143.16 (dd, J = 22.6, 7.0 Hz), -147.80 (dd, J = 21.9, 18.0 Hz). 
MS (ESI) m/z =463 [(M+H)+]. 
4.2.12. 2-(2,6-Diisopropylphenyl)-4,5,7-trifluoro-6-thiomorpholinoisoindoline-1,3-dione (7b) 
Pale yellow solid. m.p.: 145–147°C. TLC: Rf=0.43 (hexane:EtOAc=6:1). C24H25F3N2O2S. 
Elemental analysis: Calcd.: C 62.32, H 5.45, N 6.06. Found: C 62.33, H 5.43, N 6.07. IR (ATR 
PRO ONE; ZnSe) ν = 1467, 1486, 1628, 1716, 1771, 2870, 2918, 2963 cm-1; 1H NMR (500 MHz, 
CDCl3 with 0.03 % TMS) δ 1.17 (t, J = 7.4 Hz, 4 CH3), 2.67 (h, J = 7.1 Hz, 2 CH), 2.75–2.82 (m, 
2 CH2), 3.60–3.66 (m, 2 CH2), 7.28 (d, J = 8.2 Hz, 2 ArH), 7.45 (t, J = 7.5 Hz, ArH). 13C-NMR 
(126 MHz, CDCl3) δ (ppm): 23.6, 27.6, 29.0, 29.2, 29.3, 52.7, 109.2–109.9 (m), 112.5–114.4 (m), 
116.4–117.7 (m), 123.6, 125.7, 130.0, 136.0–136.6 (m), 142.6 (d, J = 12.7 Hz), 144.6–144.9 (m), 
146.8, 147.1–147.7 (m), 148.8–149.1 (m), 149.4–149.8 (m), 162.6, 163.1. 19F NMR (471 MHz, 
DMSO) δ (ppm): -123.49 (t, J = 14.6 Hz), -134.54 (dd, J = 20.6, 14.3 Hz), -139.68 (dd, J = 20.8, 
16.5 Hz). MS (ESI) m/z =463 [(M+H)+]. 
4.2.13. 2-(2,6-Diisopropylphenyl)-4-(ethyl(2-hydroxyethyl)amino)-5,6,7-trifluoroisoindoline-1,3-
dione (8a) 
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Yellow semisolid. TLC: Rf=0.36 (hexane:EtOAc=4:1). C24H27F3N2O3. Elemental analysis : 
Calcd.: C 64.27, H 6.07, N 6.25. Found: C 64.30, H 6.08, N 6.25. IR (ATR PRO ONE; ZnSe) ν = 
1460, 1496, 1512, 1641, 1655, 1703, 1720, 1766, 1780, 2852, 2872, 2930, 2971, 3369 cm-1; 1H 
NMR (500 MHz, CDCl3 with 0.03 % TMS) δ 1.09 (t, J = 7.1 Hz, CH3), 1.14 (d, J = 6.8 Hz, 2CH3), 
1.18 (d, J = 6.8 Hz, 2 CH3), 2.58–2.69 (m, 2 CH), 2.92 (t, J = 6.4 Hz, OH), 3.34 (q, J = 7.1 Hz, 
CH2), 3.45 (t, J = 4.7, CH2), 3.59–3.69 (m, CH2), 7.28 (d, J = 7.8 Hz, 2 ArH), 7.46 (t, J = 7.8 Hz, 
ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 12.8, 23.4, 23.5, 29.1, 47.3, 54.3, 58.8, 114.1, 119.6, 
123.7, 125.7, 130.1, 135.6 (d, J = 8.3 Hz), 143.2 (dd, J = 270.0 Hz, 12.3 Hz), 144.4 (d, J = 264.1 
Hz), 146.7, 153.0 (dd, J = 261.4 Hz, 8.6 Hz), 162.6, 165.4. MS (ESI) m/z =449 [(M+H)+]. 
4.2.14. 2-(2,6-Diisopropylphenyl)-5-(ethyl(2-hydroxyethyl)amino)-4,6,7-trifluoroisoindoline-1,3-
dione (8b) 
Pale yellow semisolid. TLC: Rf=0.20 (hexane:EtOAc=4:1). C24H27F3N2O3. Elemental analysis : 
Calcd.: C 64.27, H 6.07, N 6.25. Found: C 64.29, H 6.07, N 6.22. IR (ATR PRO ONE; ZnSe) ν = 
1466, 1487, 1620, 1714, 1768, 2870, 2928, 2963, 3348 cm-1; 1H NMR (500 MHz, CDCl3 with 
0.03 % TMS) δ 1.17 (d, J = 6.9 Hz, 4 CH3), 1.20 (t, J = 7.1 Hz, CH3), 1.78–1.98 (m, OH), 2.61–
2.76 (m, 2 CH), 3.38–3.45 (m, CH2), 3.51 (t, J = 5.1, CH2), 3.76 (t, J = 5.1 Hz, CH2), 7.28 (d, J = 
7.8 Hz, 2 ArH), 7.46 (t, J = 7.8 Hz, ArH). 13C-NMR (126 MHz, CDCl3) δ (ppm): 13.0, 23.6, 28.9, 
47.5, 53.8, 59.9, 110.4 (d, J = 10.6 Hz), 112.8 (d, J = 13.7 Hz), 123.6, 125.7, 130.0, 135.4 (t, J = 
11.7 Hz), 143.5 (dd, J = 266.1 Hz, 15.8 Hz), 146.8, 149.5 (dd, J = 264.3 Hz, 4.3 Hz), 150.2 (ddd, 
J = 257.1 Hz, 12.8 Hz, 5.5 Hz), 162.7, 163.3. 19F NMR (471 MHz, DMSO) δ (ppm): -122.59 (t, J 
= 14.8 Hz), -134.58 (dd, J = 19.3, 15.7 Hz), -140.16 (dd, J = 20.2, 16.0 Hz). MS (ESI) m/z =449 
[(M+H)+]. 
4.3. Representative gram-scale isolation method for compound 7a: 
To a solution of 5.0g (13.2 mmol) 1 in toluene–water mixture (1:1) (50 mL) was added 1.52 g 
(13.2 mmol, 1 equiv) 1-methyl-4-hydroxypiperidine, and the reaction mixture was stirred at room 
temperature for 36 hours. Then one equivalent amine was added slowly, and the reaction mixture 
was stirred for an additional 24 hours at room temperature. The reaction was monitored by TLC 
(eluent: n-hexane:EtOAc 6:1). Once the reaction was completed, the mixture was diluted with 
ethyl acetate (100 mL), and the organic phase was extracted with water (2 x 100 mL). The organic 
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phase was dried over Na2SO4, filtered and evaporated. The crude products were isolated by 
crystallization with heptane:EtOAc mixture (5:1) to yield pure compound 7a (2.31 g, 38%) 
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Figure 1. The regioselective outcomes of the SNAr transformation of the perfluorinated 
phthalimide 
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Figure 2. The isolated bioactive ortho substituted regioisomers 2a–8a. 
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Scheme 1. The initial regioselective SNAr outcomes of 1 with primary and secondary amines 
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Scheme 2. Regioselective SNAr efforts with application of 50 mol% FeCl3·6H2O as catalyst 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. SNAr study in toluene/water mixture with the unsoluble/unreactive amines 
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Scheme 4. The  SNAr outcomes of 1 with N-ethylethanolamine in the presence of additives 
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Scheme 5. Utilization of 1-methyl-4-hydroxypiperidine additive in the SNAr treatments of 1 
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Table 1. SNAr transformations of 1 
Compounda Amine Conversionb (%) 
Isomer ratioc (%) 
a b 
2 morpholine 98 30 70 
3 4-piperidinol 87 34 66 
4 ethylamine 95 39 61 
5 cyclopentylamine 93 17 83 
6 N-methylethanolamine 100 33 67 
7 thiomorpholine 85 8 92 
8 N-ethylethanolamine 99 28 72 
a: reaction conditions: amine (2 equiv), CH2Cl2, 24 h, r.t.; b: total conversion calculated by HPLC; c: calculated by 
HPLC. 
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Table 2. The  influence of 50 mol% FeCl3·6H2O for the SNAr outcomes  
Compounds Amine Conversiona (%) 
Isomer ratiob (%) 
a b 
2 morpholine 83 84 16 
3 4-piperidinol 0 0 0 
4 ethylamine 65 80 20 
5 cyclopentylamine 75 71 29 
6 N-methylethanolamine 64 48 52 
7 thiomorpholine 0 0 0 
8 N-ethylethanolamine 54 66 34 
a: reaction conditions: amine (1 equiv), 50 mol% FeCl3·6H2O, toluene, 24 h, r.t.; b: total conversion calculated by 
HPLC; c: calculated by HPLC 
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Table 3. The solvent effect ( toluene/water mixture) for the SNAr outcomes; without additive 
Compounds Amine Conversiona (%) 
Isomer ratiob (%) 
a b 
3 4-piperidinol 77 100 0 
6 N-methylethanolamine 68 81 19 
7 thiomorpholine 72 80 20 
8 N-ethylethanolamine 91 51 49 
a: reaction conditions: amine (1 equiv), toluene:water 1:1, 24 h, r.t.; b: total conversion calculated by HPLC; c: 
calculated by HPLC 
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Table 4. The effect of tertiary 1,2- and 1,3-aminoalcohols on the ratios of 8a and 8b 
Additivea Conversionb (%) 
Isomer ratioc (%) 
8a 8b 
- 90 51 49 
1-methyl-4-hydroxypiperidine 95 88 12 
2-diethylaminoethanol 82 58 42 
2-dimethylaminoethanol 63 67 33 
N,N-dimethylethylamine 66 65 35 
4-methylmorpholin 65 72 28 
DABCO 71 45 55 
DBU 95 33 67 
 
61 61 39 
a: using one equivalent of the corresponding additive; b: total conversion calculated by HPLC; c: calculated by HPLC 
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Table 5. SNAr outcomes in the presence of 1-methyl-4-hydroxypiperidine 
Compounds Amine 
Conversiona 
(%) 
Isomer ratiosb (%) 
a b 
2 morpholine 86 81 19 
3 4-piperidinol 100 83 17 
4 ethylamine 100 79 21 
5 cyclopentylamine 89 80 20 
6 N-methylethanolamine 91 89 11 
7 thiomorpholine 87 91 9 
8 N-ethylethanolamine 91 88 12 
a: reaction conditions: 1-methyl-4-hydroxypiperidine (1 equiv), amine (1 equiv), toluene:water 1:1, 60 h, r.t.; b: total 
conversion calculated by HPLC; c: calculated by HPLC 
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